This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.

Looking toward approval in the US, larger studies with careful hemodynamic data will be needed, says Martin Leon.

The Myval THV series demonstrated non-inferiority to contemporary THVs in terms of 1-year clinical efficacy composite endpoint (Myval THV Series: 13% vs. Contemporary THV: 13.1%, difference: -0.1% ...

Meril has announced the appointment of Biplab G. as its Business Head - APAC, Arthroplasty Portfolio, based in Mumbai, with a ...

Emeril Lagasse inspired his daughters and son's love of food Emeril Lagasse’s four children — Jessica, Jillian, E.J and Meril — have all followed in his culinary footsteps in one way or another.

As legal battles continue between the manufacturers, the COMPARE-TAVI 1 trial has demonstrated that the Myval and Myval Octacor transcatheter heart valves (Meril Life Sciences) compare favorably with ...

The 26th edition of the Meril-Prothom Alo Awards was held at the Bangladesh-China Friendship Conference Centre in Agargaon ...

First-of-its-kind head-to-head TAVI trial reinforces the performance and safety of the Next Gen Myval THV series VAPI, India, May 22, 2025 /PRNewswire/ -- Meril Life Sciences announced one-year ...

Mr. Sanjeev Bhatt, Senior Vice President – Corporate Strategy at Meril, said: "The LANDMARK trial represents a significant milestone not just for Meril, but for the global TAVI community.